Project Grant R01EB036987

Award Date 4/1/25
Completion Date 1/31/29
Dollars Obligated $547K
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $373,383 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program to Mayo Clinic. The grant, with a performance period from June 1, 2024 to March 31, 2028, aims to improve the dose efficiency of photon counting computed tomography (CT) imaging. Key objectives include: 1) developing hardware to increase the fraction of detected x-ray...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $450,632 Project Grant (R01EB035394) under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program to The General Hospital Corporation (Massachusetts General Hospital) to develop and validate deep learning-based algorithms to improve the image quality of mobile photon-counting CT (PCCT) scanners used in the neuroscience intensive care unit. The key goals are...
This $647,398 Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to develop novel, non-invasive magnetic resonance imaging (MRI) biomarkers to assess the efficacy of new molecularly targeted therapies for myelofibrosis, a fatal blood cancer. The 5-year project will leverage advanced MRI techniques including Dixon, diffusion-weighted imaging, and magnetization transfer imaging to quantify changes in bone marrow...
The U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,405,883 Cooperative Agreement (CFDA 93.286) to the University of California, Davis to develop a novel Multiple X-Ray Source Array (MXA) computed tomography (CT) imaging system. The project aims to design, fabricate, and test a multi-source X-ray tube and a prototype tabletop CT scanner to demonstrate improved image quality and reduced cone beam artifacts compared to conventional single-source CT...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $502,841 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to The Regents of the University of California, operating as Lawrence Berkeley National Laboratory (LBNL). The funding will support research and development of a novel detector readout concept for monolithic scintillation detectors that enables direct...
This $700,611 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) aims to conduct a practical randomized controlled trial to evaluate the use of artificial intelligence (AI) for improving melanoma diagnosis. The study, led by the Sloan-Kettering Institute for Cancer Research, will determine the potential benefits and barriers of AI technology adoption by clinicians, and assess the impact of real-time AI feedback on...
The National Cancer Institute (NCI) awarded a $593,383 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to The Methodist Hospital Research Institute to develop an AI-enhanced, label-free multimodal optical microscopy system for rapid and precise diagnosis of thyroid cancer and lymph node metastasis. The project aims to streamline the diagnostic process and minimize complications by eliminating the need for external dyes. The key products to be delivered...
The National Cancer Institute (NCI) awarded a $673,366 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to the University of Chicago for the development of a novel X-ray dual-energy cone-beam microCT (DECB-microCT) imaging system to enhance intraoperative identification of positive margins in breast-conserving surgery. The key objectives are to: (1) develop the DECB-microCT system for quantitative lumpectomy specimen imaging; (2) acquire highly-sampled...
This $783,176 Project Grant, awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to demonstrate the clinical utility of photon-counting detector computed tomography (PCD-CT) in characterizing bone quality in the vertebrae of patients undergoing pharmacologic therapy for osteoporosis. The grant will fund the development and validation of a quantitative spine...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) totaling $677,998 will fund a study to externally validate and integrate radiomics-based models for identifying the extent of glioma tumor infiltration and heterogeneity. The Medical College of Wisconsin (MCW) will lead this research, which aims to refine and clinically validate radiomics algorithms to more accurately characterize glioma tumor biology throughout a patient's...

This National Institute of Biomedical Imaging and Bioengineering (NIBIB) Project Grant award under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program supports the development of AI-assisted quantitative photon-counting-detector CT (PCD-CT) imaging techniques for improved cytogenetic risk prediction and treatment response monitoring in multiple myeloma patients. The $546,874 award, spanning Apr 2025 to Jan 2029, aims to create an imaging-based risk stratification model and derive quantitative PCD-CT biomarkers of bone marrow composition to better detect and manage multiple myeloma. The project leverages the capabilities of advanced PCD-CT imaging and AI algorithms to address limitations of current invasive diagnostic approaches and enable more comprehensive disease assessment across the whole skeleton. Mayo Clinic, the prime awardee, will collaborate on this effort to translate these innovative imaging technologies into clinical tools for improved multiple myeloma diagnosis, prognostication, and treatment monitoring.

Generated 4/8/25, 5:41 AM